Negative association between serum perfluorooctane sulfate concentration and bone mineral density in US premenopausal women: NHANES, 2005-2008

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 6, 2014, Pages 2173-2180

  Lin, Lian Yu ^a   Wen, Li Li ^b   Su, Ta Chen ^b   Chen, Pau Chung ^a,c   Lin, Chien Yu ^b,d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b EN CHU KONG HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUOROOCTANE SULFATE; PERFLUOROOCTANOIC ACID; SULFATE; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD LEVEL; BONE DENSITY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; LUMBAR SPINE; MALE; MEDICAL HISTORY; MEXICAN AMERICAN; OSTEOARTHRITIS; OSTEOPOROSIS; PREMENOPAUSE; PRIORITY JOURNAL; SELF REPORT; SEX DIFFERENCE; UNITED STATES;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREMENOPAUSE; SULFATES; UNITED STATES; YOUNG ADULT;

EID: 84902348769     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3409     Document Type: Article

References (48)

1. Greendale GA, Barrett-Connor E, Ingles S, Haile R. Late physical and functional effects of osteoporotic fracture in women: the Rancho Bernardo study. J Am Geriatr Soc . 1995;43:955-961.
2. National Osteoporosis Foundation. Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Osteoporos Int. 1998;8(suppl 4):S1-S88.
3. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2 001;286:2815-2822.
4. Cauley JA, DanielsonME,BoudreauRM,et al. Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res. 2007;22: 1088-1095.
5. Agas D, Sabbieti MG, Marchetti L. Endocrine disruptors and bone metabolism. Arch Toxicol. 2013;87:735-751.
6. Miller RW. Congenital PCB poisonin g: a reevaluation. Environ Health Perspect. 1985;60:211-214.
7. Beard J, Marshall S, Jong K, et al. 1,1,1-Trichloro-2,2-bis (p-chlorophenyl)-ethane (DDT) and reduced bone mineral density. Arch Environ Health. 2000;55:177-180.
8. Glynn AW, Michaelsson K, Lind PM, et al. Organochlorines and bone mineral density in Swedish men from the general population. Osteoporos Int. 2000;11:1036-1042.
9. Wallin E, Rylander L, Hagmar L. Exposure to persistent organochlorine compounds through fish consumption and the incidence of osteoporotic fractures. Scand J Work Environ Health. 2004; 30:30-35.
10. Houde M, Martin JW, Letcher RJ, Solomon KR, Muir DC. Biological monitoring of polyfluoroalkyl substances: a review. Environ Sci Technol. 2006;40:3463-3473.
11. Lau C, A nitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci. 2007;99:366-394.
12. Thibodeaux JR, Hanson RG, Rogers JM, et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci. 2003;74:369-381.
13. Biegel LB, Hurtt ME, Frame S R, O'Connor JC, Cook JC. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol Sci. 2001;60:44-55.
14. Wei Y, Dai J, Liu M, et al. Estrogen-like properties of perfluorooctanoic acid as revealed by expressing hepatic estrogen-responsive genes in rare minnows (Gobiocypris rarus). Environ Toxicol Chem. 2007;26:2440-2447.
15. Shi Z, Zhang H, Liu Y, Xu M, Dai J. Alterations in gene expression and testosterone synthesis in the testes of male rats exposed to perfluorododecanoic acid. Toxicol Sci. 2007;98:206-215.
16. Seacat AM Thomford PJ Hansen KJ Olsen GW Case MT Butenhoff JL Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys Toxicol Sci. 2002 68 249-264.
17. Qian Y, Ducatm an A, Ward R, et al. Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability. J Toxicol Environ Health A. 2010;73:819-8 36.
18. Shi X, Zhou B. The role of Nrf2 and MAPK pathways in PFOSinduced oxidative stress in zebrafish embryos. Toxicol Sci. 2010; 115:391-400.
19. Melzer D, Rice N, Depled ge MH, Henley WE, Galloway TS. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the US National Health and Nutrition Examination Survey. Environ Health Perspect. 2010;118:686-692.
20. Wen LL, Lin LY, Su TC, Chen PC, Lin CY. Association between serum perfluorinated chemicals and thyroid function in US adults: the National Health and Nutrition Examination Survey, 2007-2010. J Clin Endocrinol Metab. 2013;98:E1456-E1464.
21. Lopez-Espinosa MJ, Fletcher T, Armstrong B, et al. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with age of puberty among children living near a chemical plant. Environ Sci Technol. 2011;45:8160-8166.
22. Kuklenyik Z, Needham LL, Calafat AM. Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction. Anal Chem. 2005;77:6085-6091.
23. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. Polyfluoroalkyl chemicals in the US population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect. 2007;115:1596-1602.
24. Genant HK, Engelke K, Fuerst T, et al. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res. 1996; 11:707-730.
25. Management of osteoporosis in postmenopausal women: position statement of the North American Menopause Society. Menopause. 2010;17:25-54; quiz 55-56.
26. Hodgson SF, Watts NB, Bilezikian JP, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with sel ected updates for 2003. Endocr Pract. 2003; 9:544-564.
27. Weitzman M, Cook S, Auinger P, et al. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Circulation. 2005;112:862-869.
28. Adeeko A, Li D, Forsyth DS, et al. Effects of in utero tributyltin chloride exposure in the rat on pregnancy outcome. Toxicol Sci. 2003;74:407-415.
29. Kamei S, Miyawaki J, Sakayama K, Yamamoto H, Masuno H. Perinatal and postnatal exposure to 4-tert-octylphenol inhibits cortical bone growth in width at the diaphysis in female mice. Toxicology. 2008;25 2:99-104.
30. Finnila MA, Zioupos P, Herlin M, et al. Effects of 2,3,7,8- tetrachlorodibenzo-p-dioxin exposure on bone material properties. J Biomech. 2010;43:1097-1103.
31. Nimrod AC, Benson WH. Environmental estrogenic effects of alkylphenol ethoxylates. Crit Rev Toxicol. 1996;69:335-364.
32. Sabbieti MG, Agas D, Palermo F, et al. 4-Nonylphenol triggers apoptosis and affects 17-estradiol receptors in calvarial osteoblasts. Toxicology. 2011;290:334-341.
33. Schantz SL, Widholm JJ. Cognitive effects of endocrine-disrupting chemicals in animals. Environ Health Perspect. 2001;109:1197-1206.
34. Hodgson S,ThomasL, Fattore E, et al. Bone mineral density changes in relation to environmental PCB exposure. Environ Health Perspectives. 2008;116:1162-1166.
35. Knox SS, Jackson T, Frisbee SJ, Javins B, Ducatman AM. Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project. J Toxicol Sci. 2011;36:403-410.
36. Lopez-Espinosa MJ, Mondal D, Armstrong B, Bloom MS, Fletcher T. Thyroid function and perfluoroalkyl acids in children living near a chemical plant. Environ Health Perspectives. 2012;12 0:1036-1041.
37. Lin CY Wen LL Lin LY et al The associations between serum perfluorinated chemicals and thyroid function in adolescents and young adults J Hazard Mater. 2013 244-245 637-644.
38. Long M, Ghisari M, Bonefeld-Jørgensen EC. Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor. Environ Sci Pollut Res Int. 2013 ;20:8045-8056.
39. Kjeldsen LS, Bonefeld-Jø rgensen EC. Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res Int. 2013;20:8031-8044.
40. Fei C, McLaughlin JK, Lipworth L, Olsen J. Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod. 2009;24: 1200-1205.
41. Vestergaard S, Nielsen F, Andersson AM, et al. Association between perfluorinated compounds and time to pregnancy in a prospective cohort of Danish couples attempting to conceive. Hum Reprod. 2012;27:873-880.
42. KnoxSS, Jackson T, Ja vins B, Frisbee SJ, Shankar A, DucatmanAM. Implications of early menopause in women exposed to perfluorocarbons. J Clin Endocrinol Metab. 2011;96:1747-1753.
43. Finkelstein JS, Neer RM, Biller BM, Crawford JD, Klibanski A. Osteopenia in men with a history of delayed puberty.NEngl J Med. 1992;326:600-604.
44. Chevalley T, Bonjour JP , Ferrari S, Rizzoli R. Influence of age at menarche on forearm bone microstructure in healthy young women. J Clin Endocrinol Metab. 2008;93:2594-2601.
45. Liu C, Du Y, Zhou B. Evaluatio n of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes. Aquat Toxicol. 2007;85:267-277.
46. Lind PM, Milnes MR, Lundberg R, Bermudez D, Orberg JA, Guillette LJ Jr. Abnormal bone composition in female juvenile American alligators from a pesticide-polluted lake (Lake Apopka, FL). Environ Health Perspectives. 2004;112:359-362.
47. Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995;333:1437-1443.
48. PocockNA,Eisman JA, YeatesMG,Sambrook PN, Eberl S. Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density. J Clin Invest. 1986;78:618-621.